Quality

The focus of quality improvement in healthcare is to bolster performance and processes related to diagnostic and therapeutic procedures. Leaders in this space also ensure the proper selection of imaging exams and procedures, and monitor the safety of services, among other duties. Reimbursement programs such as the Merit-based Incentive Payment System (MIPS) utilize financial incentives to improve quality. This also includes setting and maintaining care quality initiatives, such as the requirements set by the Joint Commission.

Thumbnail

Where Medicaid coverage is most prevalent

Medicaid has undergone significant changes over the last several years, both after states were allowed to expand the federal program under the Affordable Care Act and after President Trump recently announced states will be allowed to cap spending for the program.

Thumbnail

Top patient safety concerns of 2020

Missed and delayed diagnosis is the top patient safety concern of 2020, according to a new list from ECRI.

Thumbnail

Best hospitals in the world 2020

For the second year in a row, Newsweek has ranked the best hospitals in the world in partnership with global research company Statista.

Thumbnail

Google faces more backlash over health data privacy concerns

Google has been partnering up with healthcare industry titans over the last few years in data exchange contracts that continue to draw criticism, Business Insider reported.

Thumbnail

Two new studies confirm replacing red meat with plant protein lowers risk of dying, heart disease

Another round of studies prove that consuming red and processed meat is bad for health. The studies, both from Harvard researchers, were presented at the American Heart Association’s EPI Scientific Sessions.

Thumbnail

Diabetes drug tainted with carcinogen

A probable carcinogen NDMA has been found in a diabetes drug metformin, testing by a pharmacy has confirmed. The FDA previously announced it was testing metformin, which helps control blood sugar, for NDMA.

Thumbnail

First drug shortage reported from coronavirus

A shortage of a human drug was reported by the FDA as a result of the coronavirus. The agency has been closely monitoring the supply chain in anticipation that the virus, dubbed COVID-19, would lead to potential drug shortages.

Thumbnail

Marketers using personal Medicare under investigation

A new investigation examining how marketers are getting the personal Medicare information of seniors is underway, with government watchdogs wanting to know if a misuse of a government system is to blame, The Associated Press reported.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup